MAPflow and Pharmacists' Association of Newfoundland & Labrador Forge Strategic Alliance to Transform Pharmacy Practice

In the News

MAPflow and Pharmacists' Association of Newfoundland & Labrador Forge Strategic Alliance to Transform Pharmacy Practice

April 15, 2026

MAPflow Inc., a premier provider of pharmacist-led clinical workflow solutions, and the Pharmacists' Association of Newfoundland & Labrador (PANL) today announced a strategic partnership designed to accelerate the adoption and ongoing utilization of MAPflow's clinical platform throughout the province.

Following its successful launch in Newfoundland & Labrador earlier this year, MAPflow has been equipping pharmacists with robust workflow capabilities for minor ailment evaluations, prescribing authority, over-the-counter guidance, and chronic disease interventions. This formalized alliance with PANL builds on that momentum, delivering enhanced member advantages and unified support to pharmacists across the province.

"Joining forces with PANL enables us to expand our support for pharmacists throughout Newfoundland & Labrador," said CEO Dr. Nardine Nakhla. "Through this alliance, pharmacists in the province gain access to the same validated clinical platform delivering measurable impact in Ontario, New Brunswick, Prince Edward Island, and Manitoba—now enhanced with exclusive member pricing and association-endorsed resources."

Strategic Partnership Addresses Key Professional Priorities

The collaboration responds to critical needs identified by PANL and its membership base:

Showcasing Pharmacy's Impact – MAPflow's real-time, anonymized analytics capture clinical interventions and patient outcomes, equipping PANL with robust data to strengthen advocacy campaigns with government bodies and insurance providers.

Safeguarding Members Against Audit Exposure – Comprehensive documentation architecture aligns with provincial standards and third-party payer requirements, minimizing reimbursement recovery risk and reinforcing compliance confidence.

Strengthening Clinical Expertise – Evidence-informed decision pathways and embedded continuing education resources support point-of-care decision-making without requiring separate training sessions or additional coursework.

Delivering Exclusive Member Benefits – PANL members unlock preferential MAPflow subscription pricing, providing concrete value to professional membership and bolstering member engagement.

"This alliance reflects our commitment to advancing our members' professional practice," said Jennifer Collingwood, Executive Director at PANL. "Through our work with MAPflow, we're providing Newfoundland & Labrador pharmacists with industry-leading clinical technology, exclusive member advantages, and the evidence-based advocacy resources essential to showcasing their vital healthcare contributions."

Leveraging Demonstrated Success Across Canada

MAPflow's association-driven model has generated substantial impact nationwide. The platform captured 35% market share in Ontario following its 2022 introduction through the Ontario Pharmacists Association. Comparable collaborations with associations in New Brunswick, Prince Edward Island, and Manitoba have surpassed adoption benchmarks and supported successful policy advancement initiatives.

"Our provincial association partnerships extend beyond software implementation—they're focused on developing the evidence infrastructure that elevates pharmacy practice," added Nardine from MAPflow. "We're committed to bringing that same partnership-driven model to our collaboration with PANL."

A Shared Vision for Newfoundland & Labrador Pharmacy

The partnership embodies a unified commitment: providing Newfoundland & Labrador pharmacists with premier clinical technology while generating the measurable evidence required to advance professional recognition and enhance patient care throughout the province.

As this collaboration progresses, MAPflow and PANL will continue working together to ensure pharmacists across Newfoundland & Labrador have the resources needed to deliver outstanding patient care, adapt to evolving practice requirements, and demonstrate pharmacy's quantifiable impact to payers and health system decision-makers.

Pharmacists in Newfoundland & Labrador interested in exploring exclusive member benefits and accessing MAPflow can explore our website or reach out to PANL directly.

About the Author